Clinical Trial Update: HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings [NA]

View source ↗

Summary

A completed clinical trial evaluating high-resolution microendoscopy (HRME) for screening cervical cancer and its precursors in low-resource settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Snippet

Sponsor: Barretos Cancer Hospital | Conditions: Neoplasia of the Uterine Cervix, Cancer Prevention | NA | Status: COMPLETED